socalTECH

AUGUST 31, 2011

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , has backed the developer of a biopharmaceutical aimed at treating irritable bowel syndrome, kidney disease, and diabetes.

Thousand Oaks 150

Thousand Oaks Venture Capital Capital Funding 150

socalTECH

MAY 8, 2012

The venture capital arm of Thousand Oaks-based Amgen has placed more funding into one of its portfolio companies, Sutro Biopharma , which is working on developing a scalable biochemical protein synthesis platform aimed at cancer therapeutics. Sutro said it has raised $16.5M

Thousand Oaks 140

Thousand Oaks Invest Venture Capital Platform 140

socalTECH

JULY 8, 2010

Thousand Oaks-based Ceres , a developer of biofuels crop technology, said Thursday that it has completed a private offering of convertible preferred stock. Tags: ceres venture capital biotech lifescience biofuel energy cleantech clean crop seed. Ceres is developing improved seed varieties--including. READ MORE>>.

Thousand Oaks 140

Thousand Oaks Venture Capital Design Activity 140

socalTECH

DECEMBER 1, 2009

Thousand Oaks-based Xirrus confirmed Tuesday that it has raised an additional $20M in funding, bringing the firm's total raised to $80M. Tags: xirrus venture capital fundraising wifi networking hardware. The round was led by InterWest Partners. The round was first revealed in a regulatory filing last week. READ MORE>>.

Thousand Oaks 140

Thousand Oaks Funding Venture Capital Networking 140

socalTECH

JANUARY 22, 2010

The latest numbers from the MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association (NVCA), based on data from Thomson Reuters, were released this morning, finding that there was $587.8M Tags: reuters thomson moneytree quarterly investment capital venture. was invested in the region.

Southern California 113

Southern California Invest Venture Capital Orange County 113

socalTECH

FEBRUARY 21, 2013

Xirrus , the wireless hardware provider based in Thousand Oaks, has just raised $10.1M Xirrus, which is backed by August Capital, Canaan Partners, InterWest Partners, QuestMark Partners, and US Venture Partners, last announced a funding round back in September. in a funding round, part of an ongoing $11.0M

Thousand Oaks 164

Thousand Oaks Conference Networking Capital 164

socalTECH

DECEMBER 31, 2012

venture capital exits in. 2011, showing a reduced number of exits--but more IPOs--in venture backed companies. Ceres Closes IPO - Among the few Southern California IPOs, Thousand Oaks-based biofuels seed technology provider Ceres has its IPO in April. a share last week, down from its IPO debut of $13.00

Southern California 211

Southern California Thousand Oaks Incubator SpaceX 211

socalTECH

JULY 9, 2012

Thousand Oaks-based wireless equipment maker Xirrus appears to have raised $18.4M According to the filing, representatives of US Venture Partners, August Capital, Alta Partners, and Canaan Partners all have board seats. more in a funding round, part of an ongoing $25.3M READ MORE>>.

Thousand Oaks 140

Thousand Oaks Funding Capital Companies 140

socalTECH

MARCH 8, 2016

Thousand Oaks-based Amgen has made another investment this morning in immunology startup Tizona Therapeutics , via its venture capital arm, Amgen Ventures. Series A investors--including Amgen Ventures--also participated, with investments from MPM Capital, Astellas Venture Management and InterWest Partners.

Thousand Oaks 100

Thousand Oaks Funding Venture Capital Invest 100

socalTECH

MAY 9, 2018

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , is one of the investors in a Boston biotech company, Akili Interactive. Akili is developing digital medicine products aimed at treating cognitive dysfunction, including ADHD, multiple sclerosis, and depression. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Funding Venture Capital Capital 100

socalTECH

OCTOBER 9, 2015

Thousand Oaks-based Amgen has seen an exit out of its startup investment portfolio, and activities of its Amgen Ventures venture capital arm, at Berkeley-based Adheron Therapeutics this morning. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Venture Capital Activity Capital 100

socalTECH

SEPTEMBER 27, 2012

In a proof that it's not all social media and e-commerce here in Southern California, number two ranking startup in The Wall Street Journal's ranking of the "Top 50 Startups" is none other than wireless hardware provider Xirrus , based in Thousand Oaks. That list included Laguna Hills-based Glaukos at number 7; Donuts Inc. ,

West Hollywood 145

West Hollywood Thousand Oaks Southern California Journal 145

socalTECH

JANUARY 9, 2017

Thousand Oaks-based Amgen is the lead investor in a round for San Francisco- and Bozeman, Montana-based SiteOne Therapeutics , SiteOne said on Friday. SiteOne said it raised $15M in a Series B funding round, which was led b Amgen, and also included Next Frontier Capital and insiders.

Thousand Oaks 100

Thousand Oaks Invest Capital Funding 100

socalTECH

JULY 25, 2018

South San Francisco-based Alector , a biotechnology company focused on finding treatments for neurodegenerative diseases and cancer, announced Wednesday that it has raised $133M in a Series E funding round. Alector said the financing will go to advance its clinical programs and expand the company's discovery platform. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Capital Platform Funding 100

socalTECH

APRIL 29, 2021

Thousand Oaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.

Westlake Village 113

Westlake Village Thousand Oaks Funding CalTech 113

socalTECH

JANUARY 7, 2016

Thousand Oaks-based biotech giant Amgen is the a new investor in a round for Alector , a developer of immuno-modulatory therapies for Alzheimer's disease and other neurogenerative disorders, which announced a $29.5M funding today. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Google Research Funding 100

socalTECH

DECEMBER 19, 2018

Thousand Oaks-based Amgen and Swiss biotech company Molecular Partners AG said Tuesday that the two are in a collaboration and licensing deal, for the commercialization of a molecule aimed at the immuno-oncology area.

Thousand Oaks 113

Thousand Oaks Design Activity Develop 113

socalTECH

JULY 6, 2015

Thousand Oaks-based Teledyne Technologies has increased its stake in San Diego-based Ocean Aero , a developer of unmanned, robotic underwater and surface vehicles used for the scientific, defense, and oil and gas market, the company said late Friday. Financial terms of the deal were not disclosed.

Thousand Oaks 100

Thousand Oaks San Diego Invest Marketing 100

socalTECH

MAY 6, 2016

Thousand Oaks-based Amgen has helped to back a new, life sciences fund, managed by San Francisco-based venBio , as an anchor supporter of a new fund. venBio did not say how much Amgen committed to the fund, which is venBio's second life sciences fund.

Thousand Oaks 100

Thousand Oaks Funding Help Technology 100

socalTECH

DECEMBER 8, 2022

Thousand Oaks-based Dantari has raised $47M in its Series A funding, saying that it has launched a new, clinical-stage biotechnology company developing targeted therapeutics for the treatment of cancers and other diseases.

Westlake Village 100

Westlake Village Thousand Oaks CalTech Funding 100

socalTECH

APRIL 24, 2012

George Rathmann , the founding CEO of Thousand Oaks biotech giant Amgen , has died, the company announced late Monday evening. Rathman helped secure Amgen's venture capital funding and guide Amgen to its IPO, as well as growing the company to one of the largest biotech firms in the world.

Thousand Oaks 150

Thousand Oaks Guide Venture Capital Capital 150

socalTECH

JANUARY 5, 2017

the founding shareholder and chairman and treasurer of Thousand Oaks-based Amgen , has died, at the age of 90. Bowes--who also founded venture capital firm USVP --died peacefully in his home on December 28th. Bowes, Jr. , Amgen said that "without Bowes, there would be no Amgen".

Thousand Oaks 113

Thousand Oaks Venture Capital Capital Invest 113